Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy
Sponsor: Aultman Health Foundation
This PHASE4 trial investigates Wound Infection and is currently completed. Aultman Health Foundation leads this study, which shows 10 recorded versions since 2007 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Nov 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Oct 2018 — Nov 2018 [monthly]
Completed PHASE4
Phase: NA → PHASE4
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aultman Health Foundation
For direct contact, visit the study record on ClinicalTrials.gov .